Neuropeptide Y in the medial habenula alleviates migraine-like behaviors through the Y1 receptor.

"Declarations Ethics approval and consent to participateAll data in this manuscript were collected from animals and all experimental procedures were approved by the Institutional Animal Care and Use Committee of the Chinese People’s Liberation Army (PLA) General Hospital. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This work was supported by the National Natural Science Foundation of China (grants 82271242 and 82071226 to S.Y., 82171208 to Z.D., 81901134 to X.H.), the National Key Research and Development Program of China (grant 2022YFC2703600 to S.Y.), and the Logistics Support Research Project of China (grant 145BHQ090003000X12 to S.Y.)."